Related references
Note: Only part of the references are listed.The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6)
Jane Bayani et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2012)
Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease
Sudad Saman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Soluble α-Synuclein Is a Novel Modulator of Alzheimer's Disease Pathophysiology
Megan E. Larson et al.
JOURNAL OF NEUROSCIENCE (2012)
Cerebrospinal Fluid Biomarkers for Parkinson Disease Diagnosis and Progression
Min Shi et al.
ANNALS OF NEUROLOGY (2011)
Stimulatory effect of α-synuclein on the tau-phosphorylation by GSK-3ß
Fumitaka Kawakami et al.
FEBS JOURNAL (2011)
The role of alpha-synuclein in neurotransmission and synaptic plasticity
Furong Cheng et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2011)
α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
Christian Hansen et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Induction of Intracellular Tau Aggregation Is Promoted by α-Synuclein Seeds and Provides Novel Insights into the Hyperphosphorylation of Tau
Elisa A. Waxman et al.
JOURNAL OF NEUROSCIENCE (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study (vol 10, pg 230, 2011)
B. Mollenhauer et al.
LANCET NEUROLOGY (2011)
Cerebrospinal Fluid Tau/α-Synuclein Ratio in Parkinson's Disease and Degenerative Dementias
Lucilla Parnetti et al.
MOVEMENT DISORDERS (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
Brit Mollenhauer et al.
LANCET NEUROLOGY (2011)
Neurosin Levels in CSF as Potential Marker for Clinical Differentiation Between Alzheimer's Disease and Dementia With Lewy Bodies
Henrietta M. Nielsen et al.
Alzheimers & Dementia (2010)
Quantification of alpha-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies
Brit Mollenhauer et al.
BIOMARKERS IN MEDICINE (2010)
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease
Zhen Hong et al.
BRAIN (2010)
Kallikrein-related peptidase 6 in Alzheimer's disease and vascular dementia
Emma L. Ashby et al.
BRAIN RESEARCH (2010)
Differential levels of α-synuclein, β-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease
Kensaku Kasuga et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Cell-Produced α-Synuclein Is Secreted in a Calcium-Dependent Manner by Exosomes and Impacts Neuronal Survival
Evangelia Emmanouilidou et al.
JOURNAL OF NEUROSCIENCE (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Extracellular neurosin degrades α-synuclein in cultured cells
Harutsugu Tatebe et al.
NEUROSCIENCE RESEARCH (2010)
Cerebrospinal fluid α-synuclein in neurodegenerative disorders-A marker of synapse loss?
Annika Ohrfelt et al.
NEUROSCIENCE LETTERS (2009)
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Paula Desplats et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
Brit Mollenhauer et al.
EXPERIMENTAL NEUROLOGY (2008)
Controlling the mass action of alpha-synuclein in Parkinson's disease
Changyoun Kim et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Cleavage of normal and pathological forms of α-synuclein by neurosin in vitro
Takashi Kasai et al.
NEUROSCIENCE LETTERS (2008)
Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy
J. Q. Trojanowski et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2007)
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Murat Emre et al.
MOVEMENT DISORDERS (2007)
Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease
Takahiko Tokuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans
AM Fagan et al.
ANNALS OF NEUROLOGY (2006)
Substrate specificity of human kallikrein 6 - Salt and glycosaminoglycan activation effects
PF Angelo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
IG McKeith et al.
NEUROLOGY (2005)
Movement disorder society task force report on the Hoehn and Yahr staging scale: Status and recommendations
CG Goetz et al.
MOVEMENT DISORDERS (2004)
Cloning and characterization of novel isoforms of the human kallikrein 6 gene
G Pampalakis et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Characterization of the enzymatic activity of human kallikrein 6: autoactivation, substrate specificity, and regulation by inhibitors
A Magklara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Characterization of a brain-related serine protease, neurosin (human kaillikrein 6), in human cerebrospinal fluid
A Okui et al.
NEUROREPORT (2001)
Human kallikrein 6 as a biomarker of Alzheimer's disease
EP Diamandis et al.
CLINICAL BIOCHEMISTRY (2000)
Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease
K Ogawa et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2000)
Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications
EP Diamandis et al.
CLINICAL BIOCHEMISTRY (2000)
Share Paper
